Search research articles
Contact Us
Filters
Showing results (451-460 of 724) with videos related to
Page
of 73
Sort By:
Journal of Internal Medicine
|
February 11, 2020
Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease
A Koller, F Fazzini, C Lamina, et al.
Clinical Genitourinary Cancer
|
October 10, 2006
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer
James O Jin, Jan Lehmann, Jerome Taxy, et al.
Science Advances
|
July 1, 2026
Dimer asymmetry in signaling of blue light sensor histidine kinases
Vladimir Arinkin, Andreas M Stadler, Stefanie S M Meier, et al.
Clinical Genitourinary Cancer
|
October 9, 2022
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
David J VanderWeele, Masha Kocherginsky, Sabah Munir, et al.
International Journal of Cancer
|
December 1, 1994
Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer
A E Oberli-Schrämmli, F Joncourt, M Stadler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1982
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1
T A Luger, B M Stadler, B M Luger, et al.
Biology of Reproduction
|
January 23, 2026
RUNX Proteins and CBFβ Create an Interconnected Network of Transcriptional Regulation in the Male Germline
Mustika Rahmawati, Carson J Black, Danika D Dalvi, et al.
Investigational New Drugs
|
September 15, 2010
A phase I study of continuous infusion cilengitide in patients with solid tumors
Peter H O'Donnell, Samir D Undevia, Walter M Stadler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 15, 2015
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method
A Hillarp, K D Friedman, D Adcock-Funk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer
Walter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.
Page
of 73
Search research articles
Search
Showing results (451-460 of 724) with videos related to
Sort By:
Page
of 73
Journal of Internal Medicine
|
February 11, 2020
Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease
A Koller, F Fazzini, C Lamina, et al.
Clinical Genitourinary Cancer
|
October 10, 2006
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer
James O Jin, Jan Lehmann, Jerome Taxy, et al.
Science Advances
|
July 1, 2026
Dimer asymmetry in signaling of blue light sensor histidine kinases
Vladimir Arinkin, Andreas M Stadler, Stefanie S M Meier, et al.
Clinical Genitourinary Cancer
|
October 9, 2022
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
David J VanderWeele, Masha Kocherginsky, Sabah Munir, et al.
International Journal of Cancer
|
December 1, 1994
Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer
A E Oberli-Schrämmli, F Joncourt, M Stadler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1982
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1
T A Luger, B M Stadler, B M Luger, et al.
Biology of Reproduction
|
January 23, 2026
RUNX Proteins and CBFβ Create an Interconnected Network of Transcriptional Regulation in the Male Germline
Mustika Rahmawati, Carson J Black, Danika D Dalvi, et al.
Investigational New Drugs
|
September 15, 2010
A phase I study of continuous infusion cilengitide in patients with solid tumors
Peter H O'Donnell, Samir D Undevia, Walter M Stadler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 15, 2015
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method
A Hillarp, K D Friedman, D Adcock-Funk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer
Walter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.
Page
of 73